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ABSTRACT 23 
Inhibition of lactate dehydrogenase (LDH) represents an innovative approach to tackle cancer 24 
because this peculiar glycolytic metabolism is characteristic of most invasive tumor cells. An 25 
investigation into the biological properties of saffron extracts led to the discover of their LDH-26 
inhibition properties. In particular, the most important saffron components, crocetin, was found to 27 
inhibit LDH (IC50 = 54.9 ± 4.7 µM). This carotenoid was independently produced by chemical 28 
synthesis, and its LDH-inhibition properties manifested via  its antiproliferative activity against two 29 
glycolytic cancer cell lines (A549 and HeLa, IC50 = 114.0 ± 8.0 and 113.0 ± 11.1 μM, respectively). 30 
The results described in this article suggest that saffron may be a helpful alimentary component in 31 
the prevention of cancer that  potentially contributes to the efficacy of approved cancer therapies. 32 
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INTRODUCTION 41 
Inhibition of lactate dehydrogenase (LDH) as a potential anticancer strategy is rationalized via Otto 42 
Warburg’s observation that cancer cells rapidly internalize and consume glucose to survive, which in 43 
turn produces large amounts of lactate.1 In the last decade, a great interest was directed towards the 44 
discovery of antiglycolytic agents capable of interfering with the glycolytic metabolism of cancer 45 
cells.2,3 In this context, the human homotetrameric isoform 5 of lactate dehydrogenase (hLDH-5), 46 
composed of four A subunits, is considered a strategic target to selectively disrupt the metabolism of 47 
cancer cells. Moreover, hLDH-5 is overexpressed in many types of tumours. hLDH-5 catalyzes the 48 
last step of glycolysis - the reversible reduction of pyruvate to lactate via the simultaneous oxidation 49 
of NADH to NAD+.  Considering the essential role of this enzyme in the regeneration of NAD+ and 50 
continuation of glycolysis, we hypothesized its inhibition should lead to cancer cell death by 51 
starvation. Individuals that lack of hLDH-5 experience myoglobinuria after intense anaerobic 52 
exercise yet are healthy under ordinary circumstances. Therefore, we hypothesize that the inhibition 53 
of hLDH-5 is a potentially safe approach to treating cancer that will avoid the deleterious side-effects 54 
associated with traditional chemotherapy.4 Previously, hLDH-5 was silenced with siRNA, resulting 55 
in an evident decrease in cancer cell proliferation and migration.5 These results laid the groundwork 56 
for the development and the synthesis of many small molecules as hLDH-5 inhibitors and several 57 
proved to be potent inhibitors both in vitro and in vivo.6 However, the search for new potent inhibitors 58 
remains a challenging goal, since the cavity of the enzyme comprises both a cofactor (NADH)- and 59 
a substrate (pyruvate)-binding pocket. The substrate-binding site is very narrow, polar, and possesses  60 
many positively charged residues, whereas, the cofactor binding region is quite extended since NADH 61 
binds to the enzyme with the nicotinamide and adenosine portions at opposite ends of this site. 62 
Several natural products have been identified as hLDH-5 inhibitors. One of the first examples is 63 
represented by the natural derivative gossypol (Figure 1), which is extracted from the cotton seeds of 64 
the Gossypium species. Gossypol was initially studied as an antimalarial agent, due to its inhibitory 65 
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activity of the Plasmodium falciparum isoform of LDH (pfLDH). However, this compound proved 66 
to be a non-selective competitive inhibitor of LDH relative to NADH through its inhibition of the 67 
human LDH isoforms. Additionally, the high toxicity of gossypol (including cardiac arrhythmias, 68 
renal failure, muscle weakness and even paralysis) hampered its further development as an anticancer 69 
agent.7 Later, the flavonoid epigallocatechin8 (Figure 1) and the fungal metabolite panepoxydone9 70 
(Figure 1) exerted an indirect inhibitory effect on hLDH-5 by reducing its expression in cancer cells. 71 
Conversely, the α,β-unsaturated aldehyde 4‑hydroxy-2-nonenal (Figure 1), which naturally forms 72 
upon oxidation of unsaturated fatty acids, covalently binds the enzyme and blocks its activity.10 The 73 
recently identified hLDH-5 inhibitor penta-1,2,3,4,6-O-galloyl-β-D-glucose (Figure 1), a component 74 
of Rhus Chinensis gallnut extract, directly inhibits the enzyme via competitive displacement of the 75 
cofactor NADH.11 Galloflavin (Figure 1), a compound formed via autooxidation of the natural 76 
compound gallic acid, was identified by virtual screening of compounds from National Cancer 77 
Institute dataset and proved to inhibit both hLDH-5 and hLDH-1 with Ki values in the micromolar 78 
range and retard cancer cell growth.12 Luteolin 7-O-β-D-glucopyranoside (Figure 1) isolated from 79 
Phlomis kurdica, inhibits hLDH-5 with an IC50 value in the micromolar range. It was shown to be 80 
competitive with NADH; a conclusion supported by modelling studies.13 Moreover, a high-81 
throughput screening of medicinal plants identified some natural extracts, such as Chinese Gallnut 82 
(Melaphis chinensis gallnut), Bladderwrack (Fucus vesiculosus), Kelp (Laminaria Japonica) and 83 
Babul (Acacia Arabica) that showed hLDH-5 IC50 values lower than 0.001 mg/ml, although the 84 
individual chemical constituents responsible for the activity were not isolated.14 85 
Given that a growing number of natural products have demonstrated the ability to directly and 86 
indirectly hLDH-5, we screened a large panel of natural products that are mostly found in alimentary 87 
sources for the purpose of identifying new natural products as food-derived hLDH-5 inhibitors. As 88 
such, we sought to identify a possible nutraceutical strategy to produce safe antiglycolytic effects that 89 
might prove to be helpful for the prevention and treatment of cancer. In particular, we were intrigued 90 
by the well-known anticancer properties of saffron, which is one of the most expensive spices in the 91 
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world and widely known for its deep yellow colour and exquisite taste. Saffron has long been used 92 
as a medicinal herb to treat several diseases in traditional medicine, and it has found many therapeutic 93 
applications resulting from the plethora of pharmacological properties of its components.15-18 Saffron 94 
consists of the dried red stigmas of Crocus sativus Linnaeus flowers, and its main components can 95 
be grouped in three principle classes: 1) crocins: water-soluble coloured compounds that are 96 
glycosides of the carotenoid crocetin with various sugar ester moieties; 2) picrocrocin: a monoterpene 97 
glycoside that is the main substances responsible for saffron’s bitter taste; 3) safranal: the volatile oil 98 
responsible for the characteristic saffron aroma (Figure 2).19,20  99 
In order to investigate if any of the saffron components possess anti-LDH activity and contribute to 100 
its reported anticancer activity,16 we started our study by analysing the effects of this spice on the 101 
isolated enzyme. Furthermore, among the main components of saffron, it is widely documented that 102 
both crocin, the crocetin digentiobiose ester, which represents the most important glycoside 103 
carotenoid,21-24 and also the carotenoid aglycon itself, crocetin, exert anticancer and chemopreventive 104 
effects on several types of cancer cells, and some in vivo animal models.25-29 It is important to note 105 
that the average content of crocin, which behaves as a direct bioprecursor of crocetin when 106 
administered in vivo,30 is about 40 mg/g of stigmas, depending on the geographical location of the 107 
saffron source.31 Furthermore, the bioavailability of crocetin after oral administration to human 108 
volunteers proved to be highly satisfactory. It was rapidly absorbed and reached maximal plasma 109 
concentration of up to 1 uM after 4-5 hours even at the relatively low dose of 22.5 mg.32 110 
Interestingly, Kim et al. recently reported the effects of crocetin and crocin in several cancer cell 111 
lines. Crocetin induced cell death at submillimolar concentrations (IC50 values ranging from 0.16 to 112 
0.61 mM in a panel of cancer cells). However, crocin proved to be more potent in the cytotoxicity 113 
assays (IC50 values ranging from 2.87 to 5.48 µM). Both expression and activity of hLDH-5 were 114 
reduced after treatment of HeLa cells with crocetin and crocin: even in this case, crocetin was more 115 
potent than crocin, since crocetin at 1 mM reduced hLDH-5 activity by 34.2 % compared to control 116 
and crocin reached only a 10.5% inhibition at 4 mM. However, these cell-based experiments did not 117 
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determine whether crocetin or crocin directly interact with hLDH-5 because various mechanisms 118 
could be implicated at the cellular level.33 It could be predicted that the long carbon chains of these 119 
derivatives, characterized by polar moieties (carboxylic groups or sugar portions) at both the 120 
extremities, are well tolerated in the LDH active site. These preliminary results encouraged us to carry 121 
on further detailed studies in order to clarify the specific effects of crocetin and crocin on hLDH-5 122 
and in cancer cells, as described below.  123 
 124 
MATERIALS AND METHODS 125 
Chemicals. General Procedures and Materials. All solvents and chemicals were used as purchased 126 
without further purification (Aldrich, Alfa Aesar, TCI Europe). The following chemicals were used 127 
for the synthesis of the final compounds and were obtained from commercial suppliers: trans-2-128 
methyl-2-butenoic acid, methanol, sulfuric acid, diethyl ether, chloroform, N-bromosuccinimide, 129 
benzoylperoxide (70 %, remainder water), fumaraldehyde mono(dimethylacetal), 130 
(carbethoxyethylidene)triphenylphosphorane, triphenylphosphine, activated manganese dioxide, 131 
acetone, 1 M diisobutylaluminum hydride solution in anhydrous hexane, Amberlyst® 15 hydrogen 132 
form, Celite® Hyflo, ethyl acetate, hexane, dichloromethane (DCM), toluene, acetonitrile, 133 
phosphoric acid, sodium hydroxide, sodium sulphate anhydrous, potassium carbonate. 134 
Chromatographic separations were performed on silica gel columns by flash chromatography 135 
(Kieselgel 40, 0.040−0.063 mm; Merck). Reactions were followed by thin layer chromatography 136 
(TLC) on Merck aluminum silica gel (60 F254) sheets that were visualized under a UV lamp. 137 
Evaporation was performed in vacuo (rotating evaporator). Sodium sulfate was always used as the 138 
drying agent. Proton (1H) and carbon (13C) NMR spectra were obtained with a Bruker Avance III 400 139 
MHz spectrometer using the indicated deuterated solvents. Chemical shifts are given in parts per 140 
million (ppm) (δ relative to residual solvent peak for 1H and 13C). 1H-NMR spectra are reported in 141 
this order: multiplicity and number of protons. Standard abbreviation indicating the multiplicity were 142 
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used as follows: s = singlet, d = doublet, dd = doublet of doublets, ddd = doublet of doublet of 143 
doublets, t = triplet, q = quartet, dq = doublet of quartets, tq = triplet of quartets, qq = quartet of 144 
quartets, quint = quintet, m = multiplet, bq = broad quartet and bd = broad doublet. 145 
(E)-Methyl 2-methylbut-2-enoate (2). Trans-2-methyl-2-butenoic acid 1 (5.0 g; 50 mmol) was 146 
dissolved in MeOH (50 mL) in a sealed vial, concentrated H2SO4 (0.27 mL) was added dropwise and 147 
the resulting solution was heated at 90 °C for 24 h. The reaction mixture was cooled to room 148 
temperature and concentrated under reduced pressure. The resulting mixture was diluted with Et2O, 149 
and then washed successively with a saturated solution of sodium bicarbonate and brine. The organic 150 
phase was dried and evaporated under reduced pressure. The crude methyl tiglate 2 was obtained as 151 
a light yellow oil (34.1 mmol, yield 63%) and was used in the next step without further purification. 152 
1H NMR (CDCl3) δ (ppm): 1.79 (dq, 3H, J = 7.1, 1.2 Hz), 1.83 (quint, 3H, J = 1.2 Hz), 3.73 (s, 3H), 153 
6.86 (qq, 1H, J = 7.1, 1.4 Hz). 154 
(E)-Methyl 4-bromo-2-methylbut-2-enoate (3) and (Z)-methyl 2-(bromomethyl)but-2-enoate (4). 155 
Compound 2 (2.0 g; 18 mmol) was dissolved in CHCl3 (23.0 mL), then NBS (18 mmol) and 70% 156 
BPO (0.7 mmol) were added and the reaction was heated at reflux for 2 h. After cooling to room 157 
temperature, the mixture was concentrated under reduced pressure. Hexane was added to the residue 158 
and the resulting suspension was cooled in an ice bath to promote the precipitation of succinimide, 159 
which was suction filtered off. The filtrate was evaporated. The residue was diluted with AcOEt and 160 
washed with brine. The organic phase was dried and evaporated under vacuum. Mixture of γ and α-161 
bromo derivatives was obtained as an orange oil (3.08 g). 1H NMR (CDCl3) δ (ppm, assigned only 162 
significant protons): 3.77 (s, COOMe γ isomer), 3.80 (s, COOMe α isomer), 4.03 (dq, J = 8.5, 0.5 163 
Hz, CH2 γ isomer), 4.24 (s, CH2 α isomer), 6.93 (tq, J = 8.5, 1.5 Hz, vinylic proton γ isomer), 7.08 (q, 164 
J = 7.3 Hz, vinylic proton α isomer). Proton integration of these signals suggested the following 165 
composition: 68 % γ isomer, 32 % α isomer. 166 
(E)-(4-Methoxy-3-methyl-4-oxobut-2-en-1-yl)triphenylphosphonium bromide (5). Mixture of 3 and 167 
4 (3.08 g) dissolved in toluene (13.7 mL) was treated dropwise with a freshly prepared solution of 168 
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triphenylphosphine (21.6 mmol) in toluene (21.0 mL) and the reaction mixture, which became 169 
immediately cloudy, was stirred vigorously overnight. A white crystalline solid and a yellow gummy 170 
solid adherent to the walls of the flask formed: the white crystalline solid was suction filtered, washed 171 
with hexane and dried under vacuum and the yellow gummy solid was dissolved in MeOH and dried 172 
under vacuum. Both the fractions were purified by recrystallization from CH3CN/AcOEt. Compound 173 
5 (2.08 g, 4.57 mmol) was obtained as a white crystalline solid (yield on two subsequent steps: 26 174 
%).1H NMR (CDCl3) δ (ppm): 1.67 (d, 3H, J = 3.3 Hz), 3.68 (s, 3H), 5.08 (dd, 2H, J = 16.3, 8.0 Hz), 175 
6.64 (bq, 1H, J = 6.7 Hz), 7.64-7.94 (m, 15H). 176 
(E)-Methyl 2-methyl-4-(triphenylphosphoranylidene)but-2-enoate (6). To a solution of phosphonium 177 
salt 5 (1.06 g, 2.32 mmol) in CH2Cl2 (9.0 mL) was added dropwise aqueous NaOH 0.5 M (4.6 mL) 178 
and the mixture became immediately orange. After stirring for 10 minutes, the mixture was diluted 179 
with water and extracted with CH2Cl2, the organic layer was washed with brine, dried and 180 
concentrated under reduced pressure. Crude compound 6 (800 mg, 2.14 mmol) was obtained as an 181 
orange oily solid and used in the subsequent steps without further purification (yield 92%).1H NMR 182 
(CDCl3) δ (ppm, assigned only significant protons): 1.89 (s, 3H, CH3), 3.58 (s, 3H, COOMe). 183 
 (2E,4E)-Ethyl 2-methyl-6-oxohexa-2,4-dienoate (9). A solution of fumaraldehyde 184 
mono(dimethylacetal) 8 (300 mg; 0.29 mL, 2.31 mmol) in CH2Cl2 (3.6 mL) was added dropwise to 185 
a solution of (carbethoxyethylidene)triphenylphosphorane 7 (1.09 g; 3.00 mmol) in CH2Cl2 (8.9 mL). 186 
The reaction was stirred at RT overnight. Solvent was reduced under reduced pressure and then the 187 
residue was cooled in an ice bath to promote the precipitation of triphenylphosphine oxide, that was 188 
suction filtered off and washed with petroleum ether. The filtrate was concentrated, affording the 189 
dimethylacetal product in mixture with the corresponding aldehyde derivative, as a white solid (560 190 
mg). The mixture was directly subjected to the next step without further purification. The residue was 191 
dissolved in acetone (9.6 mL), then distilled water (0.15 mL) and Amberlyst 15 (prewashed with 192 
acetone, 102 mg) were added and the reaction was stirred for 1 h. After filtration to remove the resin, 193 
the filtrate was concentrated and purified by flash chromatography over silica gel (n-hexane/Et2O 194 
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85:15). Compound 9 was obtained as a yellow oil (355 mg, 2.11 mmol, yield was calculated on two 195 
subsequent steps: 91%). 1H NMR (CDCl3) δ (ppm): 1.33 (t, 3H, J = 7.1 Hz), 2.12 (d, 3H, J = 1.4 Hz), 196 
4.27 (q, 2H, J = 7.1 Hz), 6.39 (dd, 1H, J = 15.0, 7.8 Hz), 7.33 (dq, 1H, J = 11.8, 1.3 Hz), 7.42 (dd, 197 
1H, J = 14.9, 11.8 Hz), 9.70 (d, 1H, J = 7.6 Hz). 198 
(2E,4E,6E)-Diethyl 2,7-dimethylocta-2,4,6-trienedioate (10). Compound 9 (350 mg, 2.08 mmol) was 199 
dissolved in DCM (15.4 mL) and (carbethoxyethylidene)triphenylphosphorane 7 (2.72 mmol) was 200 
added. The reaction was stirred at room temperature for 2 h. The mixture was filtered through a 201 
Büchner funnel partially filled with silica gel and washed with AcOEt. The filtrate was purified by 202 
flash chromatography over silica gel (n-hexane/AcOEt 95:5). Compound 10 was obtained as a pearl-203 
white solid (342 mg, 1.36 mmol, yield 65%). 1H NMR (CDCl3) δ (ppm): 1.32 (t, 6H, J = 7.1 Hz), 204 
2.01 (d, 6H, J = 1.2 Hz), 4.23 (q, 4H, J = 7.1 Hz), 6.80 (dd, 2H, J = 7.8, 3.1 Hz), 7.28 (dq, 2H, J = 205 
7.9, 1.4 Hz).  206 
(2E,4E,6E)-2,7-Dimethylocta-2,4,6-triene-1,8-diol (11). Compound 10 (340 mg, 1.35 mmol) was 207 
dissolved in anhydrous hexane (10.4 mL) under Argon atmosphere, cooled to -78 °C and treated 208 
dropwise with a solution 1 M of DIBAL-H in anhydrous hexane (5.3 mL, 5.26 mmol). The resulting 209 
solution was stirred at the same temperature for 5 min and warmed slowly till -20 °C over 3 h. The 210 
reaction was monitored by TLC, showing that the diester was completely reacted. The reaction 211 
mixture was cooled to 0 °C and distilled water (0.3 mL) and silica gel (900 mg) were added. After 45 212 
minutes, K2CO3 (322 mg) and Na2SO4 (488 mg) were added. After 30 minutes, the solids were suction 213 
filtered off and rinsed with CH2Cl2 and AcOEt, the filtrate was concentrated to obtain compound 11 214 
as a light-yellow solid (214 mg, 1.27 mmol, yield 94%) that was used in the next step without further 215 
purification. 1H NMR (CDCl3) δ (ppm): 1.82 (s, 6H), 4.11 (s, 4H), 6.16 (dq, 2H, J = 7.5, 1.4 Hz), 216 
6.45 (dd, 2H, J = 7.3, 3.1 Hz).  217 
(2E,4E,6E)-2,7-Dimethylocta-2,4,6-trienedial (12). Compound 11 (214 mg, 1.27 mmol) was 218 
dissolved in acetone (11.5 mL) and the solution was cooled to 0 °C. Activated MnO2 (3.32 g, 38.2 219 
mmol) was added and the reaction was stirred overnight at room temperature. The mixture was 220 
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filtered in a Büchner funnel filled with celite Hyflo® and washed with acetone. The filtrate was 221 
concentrated under reduced pressure and purified by flash chromatography over silica gel (n-222 
hexane/AcOEt 85:15). Compound 12 (152 mg, 0.927 mmol) was obtained as a bright yellow solid 223 
(yield 73%). 1H NMR (CDCl3) δ (ppm): 1.95 (d, 6H, J = 1.2 Hz), 6.97-7.13 (m, 4H), 9.55 (s, 2H). 224 
(2E,4E,6E,8E,10E,12E,14E)-Dimethyl-2,6,11,15-tetramethylhexadeca-2,4,6,8,10,12,14-225 
heptaenedioate (13). A solution of compound 6 (1.83 mmol) in toluene (3.5 mL) was added to 226 
compound 12 (50.0 mg, 0.305 mmol) in toluene (1.0 mL) and the reaction was heated at 130 °C for 227 
6 h. Then, the mixture was cooled to room temperature and left under stirring overnight. Compound 228 
13 precipitated as a red brick solid, which was collected by filtration and washed with cold MeOH. 229 
The filtrate was concentrated under reduced pressure, the residue was taken up in 5 mL of MeOH and 230 
heated at 90°C for 30 minutes. The mixture was cooled to room temperature and a second fraction of 231 
pure compound 13 was collected. The total amount of pure compound 13 obtained was 61.4 mg 232 
(0.172 mmol, yield 56%). 1H NMR (CDCl3) δ (ppm): 1.99 (s, 6H), 2.00 (d, 6H, J = 1.0 Hz), 3.77 (s, 233 
6H), 6.34-6.40 (m, 2H), 6.55 (dd, 2H, J = 15.2, 10.4 Hz), 6.62 (d, 2H, J = 14.8 Hz), 6.71 (dd, 2H, J 234 
= 7.9, 2.9 Hz), 7.29 (dd, 2H, J = 10.7, 1.3 Hz). 13C NMR (CDCl3) δ (ppm): 12.94 (2C), 13.04 (2C), 235 
51.95 (2C), 123.97 (2C), 126.62 (2C), 131.48 (2C), 135.16 (2C), 136.87 (2C), 139.04 (2C), 143.90 236 
(2C), 169.09 (2C).  237 
Sodium (2E,4E,6E,8E,10E,12E,14E)-2,6,11,15-tetramethylhexadeca-2,4,6,8,10,12,14-238 
heptaenedioate (14) and (2E,4E,6E,8E,10E,12E,14E)-2,6,11,15-tetramethylhexadeca-239 
2,4,6,8,10,12,14-heptaenedioic acid (15). Diester 13 (25.0 mg, 0.0701 mmol) was suspended in 240 
MeOH (0.5 mL) and 40 % w/v NaOH (0.7 mL, 7.01 mmol) was added dropwise. The mixture was 241 
heated at reflux overnight. After consumption of the starting material, the mixture was cooled to room 242 
temperature and then to 0 °C and an orange precipitated formed. The solid was collected by filtration, 243 
washing it with cold water and cold MeOH, affording 21.9 mg (0.588 mmol) of the disodium salt 14 244 
as a bright orange solid (yield 84 %). In order to obtain the diacid 15, the work-up was accomplished 245 
by evaporating the solvent of the reaction, then the residue was diluted with water and the aqueous 246 
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phase was washed with Et2O. The aqueous layer was acidified with 10 % H3PO4, to obtain the 247 
precipitation of a red solid that was collected and washed with water and CH2Cl2 (yield 68 %). For 248 
disodium salt 14 1H NMR (D2O) δ (ppm): 1.95 (s, 6H), 2.00 (s, 6H), 6.43-6.48 (m, 2H), 6.65-6.70 249 
(m, 4H), 6.85 (dd, 2H, J = 7.9, 2.9 Hz), 6.97-7.02 (m, 2H). 13C NMR (D2O) δ (ppm): 11.92 (2C), 250 
13.42 (2C), 124.86 (2C), 131.13 (2C), 133.37 (2C), 133.96 (2C), 134.85 (2C), 137.31 (2C), 141.46 251 
(2C), 177.94 (2C). For diacid 15 1H NMR (DMSO-d6) δ (ppm): 1.91 (s, 6H), 1.97 (s, 6H), 6.43-6.53 252 
(m, 2H), 6.61 (dd, 2H, J = 14.8, 11.6 Hz), 6.72 (d, 2H, J = 15.2 Hz), 6.78-6.88 (m, 2H), 7.20 (bd, 2H, 253 
J = 10.8 Hz).  254 
Enzyme assays. The compounds were evaluated in enzymatic assays to assess their inhibitory 255 
properties against two commercially available purified human isoforms of lactate dehydrogenase, 256 
hLDH-5 (tetrameric isoform composed of four A subunits, LDH-A4, from human liver, Lee 257 
BioSolutions – USA) and hLDH-1 (tetrameric isoform composed of four B subunits, LDH-B4, from 258 
human erythrocytes, Lee BioSolutions – USA), as suspensions in 3.1 M ammonium sulfate solution, 259 
with tris chloride, DTT and EDTA, pH 8.3 Dried flower stigmas (saffron pistils) and crocin were 260 
purchased from Sigma-Aldrich. The reaction of lactate dehydrogenase was conducted using the 261 
“forward” direction (pyruvate → lactate) by using an emission wavelength at 460 nm and an 262 
excitation wavelength at 340 nm to monitor the amount of NADH consumed. These assays were 263 
conducted in wells containing 200 μL of a solution comprising the reagents dissolved in 100 mM 264 
phosphate buffer at pH 7.4. DMSO stock solutions of compounds were prepared (the concentration 265 
of DMSO did not exceed 4% during the measurements). Assays were performed in the presence of 266 
40 μM NADH and 200 μM pyruvate, combined with 0.66 ng or 0.38 mU of enzyme in a final volume 267 
of 200 µl (one unit of the enzyme reduces 1 µmol of pyruvate to L-lactate at 37 °C and pH 8.55). 268 
Seven different concentrations (in duplicate for each concentration) of the compound were used to 269 
generate a concentration–response curve. Compound solutions were dispensed in 96-well plates (8 270 
μL), and then the substrate and the cofactor dissolved in the buffer (152 μL) and the enzyme solution 271 
(40 μL) were added. Any possible background fluorescence of the tested compounds, or their 272 
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quenching of NADH fluorescence, was subtracted. In addition to the compound test wells, each plate 273 
contained maximum and minimum controls. Assay plates were incubated for 15 min, and the final 274 
measurements were performed using a Victor X3 Microplates Reader (PerkinElmer®). IC50 values 275 
were generated using the curve-fitting tool of GraphPad Prism software (GraphPad – USA). In the 276 
enzyme kinetic experiments, the same procedure previously reported by us was followed.13 The 277 
compound was tested in the presence of scalar NADH or pyruvate concentrations in the NADH or 278 
pyruvate-competition experiments, respectively. In the NADH-competition experiments, the 279 
compound was added (concentration range = 15-45 µM) to a reaction mixture containing 1.4 mM 280 
pyruvate, scalar concentrations of NADH (concentration range = 10–150 µM) and 100 mM phosphate 281 
buffer (pH = 7.4). Conversely, in the pyruvate-competition experiments, the reaction mixture 282 
contained 150 µM NADH and scalar concentrations of pyruvate (concentration range = 40–500 µM). 283 
Finally, LDH solution was added (0.015 U/mL) and the enzyme activity was measured by evaluating 284 
the NADH fluorescence decrease using a Victor X3 Microplates Reader. The experimental data were 285 
analysed with a non-linear regression analysis, using a second order polynomial regression analysis, 286 
and by applying the mixed-model inhibition fit.  287 
Cell lines and cell culture. A549 cell lines were obtained from ATCC and grown in RPMI 1640 288 
medium with 10 % fetal bovine serum, 100 U/mL penicillin, and 100 µg/mL streptomycin. HeLa cell 289 
lines were obtained from ATCC and grown in EMEM with 10 % fetal bovine serum, 100 U/mL 290 
penicillin, and 100 µg/mL streptomycin. Cells were cultured at 37 °C in a 5 % CO2– 95% air 291 
humidified atmosphere. 292 
Cytotoxicity evaluation. HeLa and A549 cells were seeded on 96 well plates at the density of 1 x 293 
103 cells per well. The cells were continuously treated with various concentrations of compound 14 294 
for 72 h. Then viability was assessed using the sulforhodamine B (SRB) assay. Cells were fixed with 295 
10% trichloroacetic acid at 4 °C for overnight and then stained with 0.057% SRB in 1 % acetic acid 296 
at room temperature for 30 min. The dye was solubilized in 10 mM Tris base (pH 10.5) and absorption 297 
at 510 nm was measured using a SpectraMax Plus 384 (Molecular Devices, Sunnyvale, CA).  Percent 298 
Page 12 of 35
ACS Paragon Plus Environment
Journal of Agricultural and Food Chemistry
13 
 
death was calculated by subtracting background from all wells and setting 0% death to vehicle-treated 299 
controls. All data are averages of at least three independent replicates. MRC5 cells (from ATCC) 300 
were maintained at 37 °C in a humidified atmosphere containing 5% CO2 accordingly to the supplier. 301 
Normal (1.5 × 104) cells were plated in 96-well culture plates. The day after seeding, vehicle or 302 
compound were added at different concentrations to the medium. Cell viability was measured after 303 
96 h according to the supplier (Promega, G7571) with a Tecan F200 instrument. IC50 values were 304 
calculated from logistical dose response curves. Averages were obtained from three independent 305 
experiments, and error bars are standard deviations (n = 3). 306 
Assessment of lactate production. HeLa human cervical carcinoma cells were seeded on 96 well 307 
plates at the density of 2.5 x 103 cells per well. When cells reached 80-90 % confluence, the cells 308 
were treated with compound or vehicle control in DMEM medium minus phenol red + 10% dialized 309 
FBS + 100 U/mL penicilin + 100 µg/mL streptomycin for 4 h. Triplicate wells were prepared for each 310 
treatment. Following treatment, the cells were fixed with 10 % trichloroacetic acid for the assessment 311 
of cell viability using SRB assay and the media were collected, and 100 µL were added to 10 µL 10 312 
mM chlorophenylalanine (CPA; the internal standard for GC-MS analysis). Samples were 313 
concentrated, derivatized by a 2h incubation with 50 µL MTBSTFA + 1% TBDMCS (Thermo 314 
Scientific, Walthman, MA) in 50 µL acetonitrile at 80 °C, and immediately analyzed using GC-MS 315 
(Agilent 6890N GC/5973 MS, equipped with an Agilent DB-5 capillary column, 30 m x 320 µm x 316 
0.25 µm, model number J&W 123-5032, Agilent Technologies, Santa Clara, CA) and electron impact 317 
ionization source. The initial oven temperature was 120 °C, held for 5 min; then the temperature was 318 
increased at a rate of 10 °C per minute until a temperature of 250 °C was reached. The temperature 319 
was then increased by 40 °C per minute until a final temperature of 310 °C was reached. The total 320 
run time per sample was 24.5 min. Compounds were identified using AMDIS Chromatogram 321 
software (Amdis, freeware available from amdis.net) and programmed WIST and Niley commercial 322 
libraries. The integration area of lactate in each sample was divided by the integration area of CPA 323 
in the same sample to achieve a lactate/internal standard ratio. The ratios were normalized by % live 324 
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and averaged for triplicates. The percentage lactate production over vehicle was calculated and all 325 
data are averages of three independent replicates. 326 
Statistical Analysis. All statistical analysis was performed using an unpaired, two-tailed student’s t 327 
test with p values < 0.05 were considered statistically significant. Values are reported as the means ± 328 
SD of three or more independent experiments. 329 
Docking Calculations. The crystal structure of the hLDH-5 protein (4M49 PDB code34), was taken 330 
from the Protein Data Bank.35 After adding hydrogen atoms, the protein was minimized using 331 
Amber14 software and the ff14SB force field at 300 K (in order to reproduce the room temperature 332 
used in the enzymatic assay).. The complex was placed in a rectangular parallelepiped waterbox, an 333 
explicit solvent model for water, TIP3P, was used and the complex was solvated with a 10 Å water 334 
cap. Sodium ions were added as counterions to neutralize the system. Two steps of minimization were 335 
then carried out; in the first stage, we kept the protein fixed with a position restraint of 500 kcal/molÅ2 336 
and we solely minimized the positions of the water molecules. In the second stage, we minimized the 337 
entire system through 5000 steps of steepest descent followed by conjugate gradient (CG) until a 338 
convergence of 0.05 kcal/Åmol. The ligands were built using Maestro and were minimized by means 339 
of Macromodel in a water environment using the CG method until a convergence value of 0.05 340 
kcal/Åmol, using the MMFFs force field and a distance-dependent dielectric constant of 1.0. 341 
AUTODOCK Tools,36 was used to define the torsion angles in the ligands, to add the solvent model 342 
and to assign partial atomic charges to the ligand and the protein. The docking site used for 343 
AUTODOCK calculations was defined in such a manner that it was constituted by all residues within 344 
10 Å of the reference ligand and NADH co-factor in the X-ray crystal structure. The energetic maps 345 
were calculated using a grid spacing of 0.375 Å and a distance dependent function of the dielectric 346 
constant. The ligand was subjected to 200 docking runs of the AUTODOCK search using the 347 
Lamarckian genetic algorithm (LGA) and employing 10 000 000 energy evaluations; the number of 348 
individuals in the initial population was set to 500 and a maximum of 10 000 000 generations were 349 
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simulated during the docking run; an rms tolerance of 2.0 Å was used to carry out the cluster analysis 350 
of the docking solutions and all the other settings were left as their defaults.  351 
MD simulations. All simulations were performed using AMBER, version 14.37 MD simulations were 352 
carried out using the ff14SB force field at 300 K. The complex was placed in a rectangular 353 
parallelepiped water box. An explicit solvent model for water, TIP3P, was used, and the complexes 354 
were solvated with a 20 Å water cap. Chlorine ions were added as counterions to neutralize the 355 
system. Prior to MD simulations, two steps of minimization were carried out using the same 356 
procedure described above. Particle mesh Ewald (PME) electrostatics and periodic boundary 357 
conditions were used in the simulation.38 The MD trajectory was run using the minimized structure 358 
as the starting conformation. The time step of the simulations was 2.0 fs with a cutoff of 10 Å for the 359 
nonbonded interaction, and SHAKE was employed to keep all bonds involving hydrogen atoms rigid. 360 
Constant-volume periodic boundary MD was carried out for 0.5 ns, during which the temperature 361 
was raised from 0 to 300 K. Then 19.5 ns of constant pressure periodic boundary MD was carried out 362 
at 300 K using the Langevin thermostat to maintain constant the temperature of our system. All the α 363 
carbons of the protein were blocked with a harmonic force constant of 10 kcal/mol•Å2 for the first 364 
3.5 ns. General Amber force field (GAFF) parameters were assigned to the ligand, while partial 365 
charges were calculated using the AM1-BCC method as implemented in the Antechamber suite of 366 
AMBER 14. The final structures of the complexes were obtained as the average of the last 16.5 ns of 367 
MD minimized by the CG method until a convergence of 0.05 kcal/mol•Å2. The average structures 368 
were obtained using the Cpptraj program39 implemented in AMBER 14. 369 
Binding Energy Evaluation. The evaluation of the binding energy associated to the different ligand-370 
protein complexes analyzed through MD simulations was carried out using AMBER 14. The 371 
trajectories relative to the last 16.5 ns of each simulation were extracted and used for the calculation, 372 
for a total of 165 snapshots (at time intervals of 100 ps). Van der Waals, electrostatic and internal 373 
interactions were calculated with the SANDER module of AMBER 14, whereas polar energies were 374 
calculated using both the Generalized Born and the Poisson−Boltzman methods with the MM-PBSA 375 
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module of AMBER 14. Dielectric constants of 1 and 80 were used to represent the gas and water 376 
phases, respectively, while the MOLSURF program was employed to estimate the nonpolar energies. 377 
The entropic term was considered as approximately constant in the comparison of the ligand−protein 378 
energetic interactions. 379 
 380 
RESULTS AND DISCUSSION 381 
LDH inhibition assays of saffron polar extract 382 
Commercially available red stigmatic lobes of saffron were dissolved in a suitable polar solvent, such 383 
as dimethyl sulfoxide (DMSO), and the polar saffron chemical constituents were extract, which we 384 
hypothesized would have a higher chance to efficiently interact with the highly hydrophilic catalytic 385 
site of hLDH-5 than non-polar components. The saffron DMSO extract was then serially diluted and 386 
tested on hLDH-5 and hLDH-1 purified isoforms to determine its inhibition potency. At the maximum 387 
tested concertation of 0.8 mg/mL, we observed an inhibition of 52% of the activity of hLDH-5 388 
(corresponding to an IC50 value of 0.653 mg/mL) and of 49% of the activity of hLDH-1 (resulting in 389 
an IC50 value of 0.717 mg/mL) by the saffron solution. The noticeable activity of the crude saffron 390 
polar extract a served as the starting point for the investigation into this dietary natural product and 391 
the identification of the constituents responsible for the inhibition of LDH enzymes.  392 
 393 
Chemical synthesis of crocetin 394 
Unlike crocin, which is commercially available at a reasonable level of purity, it was not possible to 395 
easily purchase or extract crocetin in sufficient purity and amount to complete further biological 396 
studies. Therefore, crocetin was synthesized by a multi-step synthesis. Crocetin possesses a diterpenic 397 
and symmetrical structure, possessing alternating trans double bonds in the alkyl chain, four methyl 398 
groups and carboxylic groups at both ends of the backbone. The synthesis of this carotenoid required 399 
the formation of two fragments that converged in the last steps: 1) synthesis of the central dialdehyde 400 
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unsaturated carbon chain (compound 12, Scheme 1, part B) and 2) formation of a 401 
triphenylphosphoranylide intermediate (compound 6, Scheme 1, part A), which would be condensed 402 
at both the terminal parts of the previous chain.40 The first part of this synthetic pattern was the 403 
preparation of (E)-methyl 2-methyl-4-(triphenylphosphoranylidene)but-2-enoate 6, which was 404 
condensed with dialdehyde 12 to obtain dimethyl crocetinate 13, an immediate precursor of crocetin 405 
(Scheme 1). Initially, a methanolic solution of trans-2-methyl-2-butenoic acid 1, also called tiglic 406 
acid, was heated in the presence of H2SO4 to obtain the methyl tiglate 2 (Scheme 1). Methyl tiglate is 407 
a highly volatile compound, so it was necessary to take some precautions: a) the reaction was 408 
performed in a sealed vial in order to minimize the evaporation of the product during heating, and b) 409 
the workup procedure avoided exposing this intermediate to a high vacuum. The product was obtained 410 
as a crude light yellow oil that was subsequently used in the next step without further purification. 411 
Methyl ester 2 was subjected to a radical bromination with N-bromosuccinimide (NBS) in the 412 
presence of the radical initiator benzoyl peroxide (BPO), which afforded a mixture of the two possible 413 
regioisomers, γ and α allylic bromides (compounds 3 and 4, respectively). The relative amounts of 414 
the two regioisomers were evaluated by 1H-NMR (signals of methylene protons, see experimental 415 
section) and γ and α bromides were present in a 3:2 ratio, respectively. The mixture was used in the 416 
next step without further purification. The mixture of compounds 3 and 4 was dissolved in toluene 417 
and combined with a slight excess of triphenylphosphine to get  phosphonium salts. At this time, the 418 
triphenylphosphonium salt of methyl γ-bromotiglate 5 was isolated as a pure regioisomer by 419 
recrystallization from CH3CN/AcOEt (Scheme 1). Compound 5 was treated with aqueous sodium 420 
hydroxide to afford compound 6. However the formed triphenylphosphoranylide proved to be 421 
particularly instable upon exposure to atmospheric oxygen. These observations led us to perform the 422 
reaction under an Argon atmosphere and avoid purification of this compound. The reaction was 423 
monitored via the presence of representative signals in the 1H-NMR spectrum (see experimental 424 
section) and compound 6 was prepared immediately before its use in the subsequent Wittig reaction 425 
(Scheme 1). 426 
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The second fragment of the synthesis involved the preparation of dialdehyde 12 (Scheme 1), which 427 
was to be condensed with phosphoranylide 6. The synthesis of 12 commenced with a Wittig reaction 428 
between commercially available fumaraldehyde mono(dimethyl acetal) 8 and 429 
(carbethoxyethylidene)triphenylphosphorane 7, providing a mixture of both the desired condensation 430 
product still possessing the dimethyl acetal portion (structure not shown) and condensation product 9 431 
possessing the free aldehyde moiety. This resulted the acetal group being partially removed under 432 
these reaction conditions. Considering that the next step of the synthesis involved the deprotection of 433 
the acetal moiety to obtain aldehyde 9, the mixture was treated with amberlyst 15 in a biphasic solvent 434 
system consisting of water and acetone, which lead to the complete hydrolysis of the dimethyl acetal 435 
group to afford pure aldehyde 9. Amberlyst 15 was used as an acid catalyst due to its not affecting 436 
the highly reactive double bonds present in the structure of the starting material and its ease of 437 
purification. A second Wittig reaction with (carbethoxyethylidene)triphenylphosphorane 7 gave the 438 
symmetric diester intermediate 10. Compound 10 was then reduced to form the corresponding 439 
dialcohol 11 via an excess of diisobutylaluminum hydride (DIBAL-H) and anhydrous hexane as 440 
solvent. The subsequent partial oxidation of the allylic alcoholic groups of compound 11 was 441 
performed with MnO2 to give the corresponding dialdehyde 12. Compound 12 was subjected to a 442 
double Wittig reaction with the triphenylphosphoranylide 6, thus extending the unsaturated carbon 443 
chain at both terminals. The resulting dimethyl ester of crocetin 13 precipitated as a red powder and 444 
was isolated by filtration. The precipitate was recrystallized from MeOH to obtaine material of 445 
sufficient purity. Compound 13 was saponified with aqueous NaOH to give the corresponding sodium 446 
salt (disodium crocetinate 14), which precipitated as a bright orange solid (step g, Scheme 1). 447 
Alternatively, the saponification was followed by acidification with phosphoric acid to obtain the free 448 
diacid crocetin 15 (step h, Scheme 1).41 449 
 450 
LDH inhibition assays of crocetin and crocin 451 
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Synthetic dibasic crocetin (compound 14), its dimethyl ester precursor 13, and commercially 452 
available crocin 16 were tested on hLDH-5 and hLDH-1 purified isoforms to determine their 453 
inhibitory properties, relative to galloflavin, which served as a positive control (Table 1).12 The 454 
disodium salt 14 was preferred to free acid 15 in these biological assays, since the salt form readily 455 
dissolved in the aqueous buffer without any additional organic solvent. Nevertheless, crocetin as 456 
diacid (15) was tested to confirm the inhibitory activity on the enzyme. Compound 13 was found to 457 
be completely inactive, displaying IC50 values greater than 200 µM for both isoforms. Conversely, 458 
disodium salt 14, showed noticeable inhibition of hLDH-5 (IC50 = 54.9 µM) and it was selective for 459 
this isoform, proving to be less active on isoform 1 (IC50 > 200 µM). The IC50 value of diacid 15 460 
nicely overlaps with that of its disodium salt (Table 1). Reference inhibitor galloflavin was 1.7-fold 461 
less potent than compound 14, and it also inhibited isoform 1 of the enzyme with a similar potency. 462 
Crocin 16 was less effective in the inhibition of hLDH-5 relative to crocetin, with an IC50 value 463 
similar to that of galloflavin (IC50 = 95.7 µM), and it showed selectivity towards isoform 1 (IC50 = 464 
59.8 µM). In order to complete the biochemical characterization of crocetin, a kinetic assay was 465 
performed by applying a mixed-model inhibition fit to the second order polynomial regression 466 
analysis of the rate of conversion of NADH to NAD+ to obtain Ki values in the NADH-competition 467 
experiments. In these experiments we measured an apparent Michaelis–Menten constant (KM) of 20 468 
μM and a Ki value of 25.6 µM, which is consistent with the IC50 values of both forms of crocetin 469 
(disodium salt 14 and diacid 15) reported in Table 1. Similarly, in the pyruvate-competition 470 
experiments in which the KM value was of 100 μM, the resulting Ki value was of 21.1 µM. 471 
From a structural point of view, we can conclude that the replacement of the two carboxylic acids of 472 
crocetin by methyl ester groups, as in compound 13, or the esterification with sugar moieties, as in 473 
crocin 16, led to a loss of inhibitory activity (in the case of 13) or a slight decrease in activity and a 474 
marked loss of selectivity for isoform 5 (in the case of 16), thus identifying crocetin as the most active 475 
compound among these saffron derivatives. 476 
 477 
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Inhibition of cancer cell proliferation and reduction of cellular lactate production 478 
Following the results previously obtained with isolated LDH enzyme isoforms, studies in cancer cells 479 
were focused on the disodium salt of crocetin 14 because it was found to be the most active hLDH-5 480 
inhibitor among the saffron derivatives herein studied. Compound 14 was evaluated for growth 481 
inhibitory effects on two different cancer cell lines, HeLa (human cervical carcinoma cells) and A549 482 
(human lung carcinoma cells), after 72 hours of incubation. Cell death was assessed by 483 
Sulforhodamine B (SRB) staining, as previously described42 and the cytotoxic potency of the tested 484 
compound was expressed as IC50 values, which represent the concentration of a compound that is 485 
required for the 50% inhibition of cell proliferation. Compound 14 was able to counteract cancer cell 486 
growth both in A549 and in HeLa cells with similar IC50 values of 114.0 ± 8.0 and 113.0 ± 11.1 μM, 487 
respectively (Figure 3, panel A), which may be considered as respectable values for a food 488 
component. Furthermore, 14 proved to be completely inactive against noncancerous human fibroblast 489 
lung cells (MRC5 IC50 > 500 μM).After the preliminary biochemical evaluation on the isolated 490 
enzymes and the cytotoxicity assays on two cancer cell lines, this compound was also assayed for its 491 
ability to inhibit the production of lactate in cancer cells. To this end, HeLa cells were treated with 492 
14 in phosphate buffer saline (PBS) for 6 hours and then the cell culture medium was extracted and 493 
mixed with a known amount of chlorophenylalanine (CPA, internal standard) and dried. Concentrated 494 
samples were reacted with N-methyl-N-tert-butyldimethylsilyltrifluoroacetamide (MTBSTFA) for 495 
derivatization of lactate, which was needed for its GC-MS detection and quantification. The cells 496 
were fixed and biomass was measured using SRB. Crocetin disodium salt 14 was tested at a 100 µM 497 
concentration. As previously reported, the GC-MS analysis of cell culture media for the quantitative 498 
determination of extracellular lactate was preferred over other methods, since it allows a highly 499 
sensitive determination of low micromolar lactate concentrations.43 As shown in Figure 3 (Panel B), 500 
compound 14 reduced lactate production of about 20 % compared to PBS control at 100 µM after 6 501 
h incubation.  502 
 503 
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Molecular modelling studies  504 
To rationalize how compound 14 can interact with the hLDH-5 protein, molecular docking studies 505 
followed by molecular dynamic (MD) simulations and binding energy determinations were carried 506 
out. Compound 14 was docked into the crystal structure of the hLDH-5 protein (4M49 PDB code) 507 
using AUTODOCK software.36 The 200 different docking results generated were clustered using a 508 
root-mean square deviation (RMSD) threshold of 2.0 Å and the so obtained 5 clusters of solutions 509 
were considered for further studies (see the Experimental section for details). For each cluster, the 510 
docking pose associated with the best estimated binding energy was selected as a representative 511 
binding mode. The stability of the 5 different binding modes was then assessed through 20 ns of MD 512 
simulation studies with explicit water molecules, as described in the Experimental section. The 5 MD 513 
trajectories obtained in this way were further analyzed through the Molecular Mechanics - Poisson 514 
Bolzmann Surface Area (MM-PBSA) method,44 which was shown to accurately estimate the ligand-515 
receptor energy interaction.45,46 This approach averages the contributions of gas phase energies, 516 
solvation free energies, and solute entropies calculated for snapshots of the complex molecule as well 517 
as the unbound components extracted from MD trajectories, according to the procedure fully 518 
described in the Experimental section. The MM-PBSA results (Table 2) suggest that there is one 519 
docking pose that is the most favorable, as it shows an interaction energy ΔPBSA = -29.2 kcal/mol, 520 
more than 8 kcal/mol higher than all the other binding poses (docking pose 1, Table 2).  521 
Figure 4 shows the energy minimized average structures of the last 16.5 ns of hLDH-5 complexed 522 
with the hypothesized binding pose of compound 14. The ligand interacts within the pyruvate binding 523 
site and points towards the binding site entrance. One of the two carboxylic groups forms a hydrogen 524 
bond with the catalytic H193, whereas the second carboxylic end forms a strong ionic couple with 525 
positively charged residue K57. Although the binding of the compound to the enzyme active site is 526 
mainly driven by the interactions of the two carboxylic ends, the internal carbon chain of the ligand 527 
also shows lipophilic interactions along the hLDH-5 surface and, in particular, with A30, V31, V136 528 
and I252, which represent fundamental additive contributions to the binding process. 529 
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In conclusion, an investigation into the bioactive properties of saffron extract led to the discovery of 530 
LDH-inhibitory activity, to carotenoid crocetin. Additionally, these compounds mitigated 531 
proliferation of glycolytic cancer cells. In order to unambiguously establish the effective activity of 532 
this natural compound, a multi-step chemical synthesis was implemented for the production of pure 533 
crocetin. Its moderate inhibition potency against the isolated LDH-enzyme, which frankly cannot 534 
compete with several synthetic inhibitors previously described, should not be considered as a limiting 535 
factor since crocetin is part of a spice (saffron) utilized in aliments, whose relative safety has been 536 
now established by millennia of culinary tradition employing it in many recipes. It should be 537 
acknowledged the oral LD50 for saffron in mice was found to be 20 g/kg, although oral administration 538 
of the saffron extract at concentrations from 0.1 to 5 g/kg was demonstrated to be non-toxic in mice.47 539 
Furthermore, a recent study revealed that administration of up to 400 mg / day of saffron for 1 week 540 
to healthy human volunteers did not cause any clinically significant effects,48 thus confirming its 541 
higher safety when compared to classical anticancer drugs. For these reasons, this study contributes 542 
to appreciate the role of saffron in the prevention and treatment of cancer when utilized in 543 
combination with standard-of-care preventive and therapeutic options. 544 
 545 
 546 
 547 
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Scheme 1.  
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Table 1.  
compound 
hLDH-5 hLDH-1 
IC50, μM 
 
13 
> 200 > 200 
 
14 
54.9 ± 4.7 > 200 
 
15 
61.9 ± 2.3 > 200 
 
16 
95.7 ± 9.8 59.8 ± 4.2 
 
Galloflavin 
93.2 ± 8.7 123.2 ± 14.2 
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Figure 3.  
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Table 2.  
 EEL VDW ENPOLAR EPB ΔPBSA 
Pose 1 -208.1 -29.8 -3.8 220.8 -20.9 
Pose 2 -255.1 -36.3 -4.2 285.4 -10.2 
Pose 3 -279.8 -28.6 -3.9 283.1 -29.2 
Pose 4 -218.7 -24.7 -4.1 227.4 -20.1 
Pose 5 -147.0 -22.5 -3.3 157.8 -15.0 
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Figure 4.  
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Figure 1. Some representative naturally-derived compounds that inhibit hLDH-5. 
Figure 2. Structures of saffron main metabolites. 
Figure 3. Panel A: Dose-response curve for compound 14 in A549 and HeLa cells. Panel B: Lactate 
production inhibition for compound 14 in HeLa cells quantified by GC-MS. % DEAD is less than 28 
% in all samples. Mean of three experiments. Error bars show SE (n=3). Statistical analysis was 
performed using an unpaired, two-tailed student’s t test. * p < 0.05 relative to vehicle control. 
Figure 4. Putative binding mode of compound 14 into hLDH-5. Putative binding pose of the ligand 
(green) in the binding site and view of the most relevant ligand–receptor interactions. 
Scheme 1. Reagents and conditions. Part A: a) H2SO4, MeOH, reflux; b) NBS, BPO, CHCl3, 
reflux; c) PPh3, toluene, RT; recrystallization from CH3CN/AcOEt; d) 0.5 M NaOH, DCM, RT. 
Part B: a) DCM, RT; b) Amberlyst 15, H2O, acetone, RT; c) DCM, RT; d) DIBAL-H, an. hexane, -
78 °C to -20 °C; e) activated MnO2, acetone, 0 °C to RT; f) toluene, reflux; g) aq. NaOH, MeOH, 
reflux; h) H3PO4. 
Table 1. Enzyme inhibition potencies. 
Table 2. MM-PBSA results for the five different hLDH-5-compound 14 complexes. ΔPBSA is the 
sum of the electrostatic (EEL) and van der Waals (VDW), as well as polar (EPB) and non-polar 
(ENPOLAR) solvation free energy. Data are expressed as kcal/mol. 
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